We are live on
!
Find out more
FNBOO
First National Bank of Omaha Portfolio holdings
AUM
$3.55B
1-Year Est. Return
27.24%
This Fund
S&P 500
This Quarter
Est. Return
+2.84%
1 Year Est. Return
+27.24%
3 Year Est. Return
+70.89%
5 Year Est. Return
+96.41%
10 Year Est. Return
+340.36%
AUM
$1.35B
AUM Growth
+$10.9M
(+0.81%)
Cap. Flow
-$19.4M
Cap. Flow
% of AUM
-1.44%
Top 10 Holdings %
Top 10 Hldgs %
18.9%
Holding
347
New
17
Increased
128
Reduced
121
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$4.85M |
| 2 |
Wells Fargo
WFC
|
+$4.46M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$4.45M |
| 4 |
AGN
Allergan plc
AGN
|
+$4.41M |
| 5 |
Pfizer
PFE
|
+$4.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aflac
AFL
|
+$5.9M |
| 2 |
CERN
Cerner Corp
CERN
|
+$5.11M |
| 3 |
Coca-Cola
KO
|
+$4.35M |
| 4 |
Jacobs Solutions
J
|
+$4.35M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$3.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.6% |
| 2 | Technology | 14.02% |
| 3 | Healthcare | 13.1% |
| 4 | Consumer Staples | 10.25% |
| 5 | Industrials | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
iShares Russell 2000 Growth ETF
IWO
$15B
| $1.4M | 0.1% |
10,226
-77
| -0.7% | -$10.4K |
|
152
iShares Russell Mid-Cap ETF
IWR
$57.9B
| $1.39M | 0.1% |
33,128
-888
| -3% | -$36.7K |
|
153
Altria Group
MO
$108B
| $1.39M | 0.1% |
20,083
-1,064
| -5% | -$68.1K |
|
154
RPM International
RPM
$14.7B
| $1.37M | 0.1% |
27,399
+50
| +0.2% | +$2.51K |
|
155
iShares Russell 2000 ETF
IWM
$82.2B
| $1.34M | 0.1% |
11,700
+1,805
| +18% | +$204K |
|
156
Cullen/Frost Bankers
CFR
$10.4B
| $1.3M | 0.1% |
20,370
-5,895
| -22% | -$364K |
|
157
Energy Transfer Partners
ET
$72.1B
| $1.29M | 0.1% |
89,600
| – | – |
|
|
MTSC
158
DELISTED
MTS Systems Corp
MTSC
| $1.26M | 0.09% |
28,690
+16,765
| +141% | +$843K |
|
|
CERN
159
DELISTED
Cerner Corp
CERN
| $1.22M | 0.09% |
20,891
-91,674
| -81% | -$5.11M |
|
160
AbbVie
ABBV
$440B
| $1.19M | 0.09% |
19,288
-1,382
| -7% | -$84.2K |
|
161
Zoetis
ZTS
$30.4B
| $1.19M | 0.09% |
25,166
-1,201
| -5% | -$56.7K |
|
162
UnitedHealth
UNH
$364B
| $1.16M | 0.09% |
8,228
+15
| +0.2% | +$2K |
|
163
Selective Insurance
SIGI
$5.59B
| $1.15M | 0.09% |
30,150
+50
| +0.2% | +$1.8K |
|
164
Stryker
SYK
$133B
| $1.14M | 0.08% |
9,500
-134
| -1% | -$15K |
|
165
Bristol-Myers Squibb
BMY
$130B
| $1.1M | 0.08% |
14,949
| – | – |
|
|
CFNL
166
DELISTED
Cardinal Financial Corp
CFNL
| $1.08M | 0.08% |
49,350
-25
| -0.1% | -$538 |
|
|
ESRX
167
DELISTED
Express Scripts Holding Company
ESRX
| $1.04M | 0.08% |
13,665
-703
| -5% | -$51.7K |
|
168
iShares Core S&P Small-Cap ETF
IJR
$112B
| $1.03M | 0.08% |
17,810
-350
| -2% | -$20K |
|
169
DuPont de Nemours
DD
$19.5B
| $1.03M | 0.08% |
8,161
-177
| -2% | -$23.3K |
|
170
Alliant Energy
LNT
$18.2B
| $1.03M | 0.08% |
25,882
-400
| -2% | -$14.8K |
|
171
Integra LifeSciences
IART
$1.35B
| $1.02M | 0.08% |
25,650
-150
| -0.6% | -$5.4K |
|
|
P
172
DELISTED
Pandora Media Inc
P
| $996K | 0.07% |
80,000
| – | – |
|
173
Idacorp
IDA
$8.21B
| $986K | 0.07% |
12,125
+25
| +0.2% | +$1.84K |
|
|
MBFI
174
DELISTED
MB Financial Corp
MBFI
| $966K | 0.07% |
26,625
+50
| +0.2% | +$1.73K |
|
175
GSK
GSK
$101B
| $943K | 0.07% |
17,397
-373
| -2% | -$19.6K |
|
Similar funds
TYCC
WWA
VPC
BPS
BCP
TCM
DILIC
SL
First National Bank of Omaha's Q2 2016 Portfolio in Review
As of Q2 2016, First National Bank of Omaha held 347 positions worth $1.35B, up 0.81% from $1.34B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
First National Bank of Omaha's Q2 2016 filing shows 17 new, 128 increased, 121 reduced and 31 closed positions. Its largest new stake was Boston Scientific: 223,979 shares worth $5.23M. The largest sale was Aflac, an estimated $5.9M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- First National Bank of Omaha's largest Q2 2016 buy was Boston Scientific: 223,979 shares worth $5.23M.
- First National Bank of Omaha added most to Wells Fargo in Q2 2016, an estimated $4.46M increase.
- First National Bank of Omaha's biggest Q2 2016 reduction was Aflac, cutting an estimated $5.9M.
- First National Bank of Omaha fully exited Jacobs Solutions in Q2 2016, selling an estimated $4.35M.
- First National Bank of Omaha's ten largest holdings make up 19% of its $1.35B portfolio in Q2 2016.
- First National Bank of Omaha opened 17 new positions and closed 31 in Q2 2016.
- First National Bank of Omaha's portfolio value rose 0.81% quarter-over-quarter to $1.35B.
Based on First National Bank of Omaha's 13F filing for Q2 2016, filed 19 Jul 2016.